Medtronic plc — Director's Dealing 2022

Aug 2, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2022-07-29

Reporting Person: Salmon Sean (EVP & President Cardiovascular)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-07-29	Ordinary Shares	D	5808	—	Disposed	27619	Direct

Footnotes

F1: Represents shares of performance-vesting restricted stock granted in July 2019 and earned dividend equivalent units that have been forfeited based on the Company's failure to meet the cumulative three year non-GAAP diluted earnings per share ("EPS") growth performance target.

F2: This balance increased by 344 shares due to exempt acquisitions through dividend reinvestment.